BECOME MEMBER SUPPORT
Year Cancer type Speaker
Webinar - Update In Lung Cancer - 24 August 2022
Welcome & Introduction
Biomarkers NSCLC
Ceritinib A FRONTier in the 1st Line Treatment of ALK+VE NDCLC